Atlas FDA

Cobas EGFR MUTATION TEST v2

FDA premarket approval P150047/S002 · decided 2016-10-19

Approval details

PMA number
P150047
Supplement
S002
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Cobas EGFR MUTATION TEST v2
Generic name
Somatic gene mutation detection system
Applicant
Roche Molecular Systems, Inc.
Date received
2016-09-22
Decision date
2016-10-19
Days to decision
27 days
Decision code
OK30
Product code
OWD
Advisory committee
Pathology
Expedited review
No
Location
Pleasanton, CA
Statement
Implementation of AQL sampling in place of 100% visual inspection for filling line.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
cobas® BV/CV (K260021)Roche Molecular Systems, Inc.2026-07-16
cobas CT/NG for use on the cobas 5800/6800/8800 systems; cobas TV/MG for use on the cobas 5800/6800/8800 systems (K260917)Roche Molecular Systems, Inc.2026-07-08
cobas liat CT/NG/MG nucleic acid test (K253759)Roche Molecular Systems, Inc.2026-05-15
cobas liat CT/NG nucleic acid test (K253756)Roche Molecular Systems, Inc.2026-05-15
cobas liat Bordetella panel nucleic acid test (K243753)Roche Molecular Systems, Inc.2025-11-20
cobas CMV (K252481)Roche Molecular Systems, Inc.2025-11-03
cobas HCV (K252484)Roche Molecular Systems, Inc.2025-11-03
cobas Respiratory 4-flex for use on the cobas 5800/6800/8800 Systems (K243455)Roche Molecular Systems, Inc.2025-07-31